Upregulation of AMPA receptor GluR2 (GluA2) subunits in subcortical ischemic vascular dementia is repressed in the presence of Alzheimer's disease

[1]  M. Lai,et al.  Neurochemical basis for symptomatic treatment of Alzheimer's disease , 2010, Neuropharmacology.

[2]  D. Small,et al.  Amyloid-beta decreases cell-surface AMPA receptors by increasing intracellular calcium and phosphorylation of GluR2. , 2010, Journal of Alzheimer's disease : JAD.

[3]  B. Martínez-Villayandre,et al.  AMPA receptor downregulation induced by ischaemia/reperfusion is attenuated by age and blocked by meloxicam , 2010, Neuropathology and applied neurobiology.

[4]  J. Keifer,et al.  AMPA receptor trafficking and learning , 2010, The European journal of neuroscience.

[5]  M. Lai,et al.  Cdk5-Mediated Phosphorylation of δ-Catenin Regulates Its Localization and GluR2-Mediated Synaptic Activity , 2010, The Journal of Neuroscience.

[6]  Andrea L. Rosso,et al.  Disruption of glutamate receptors at Shank-postsynaptic platform in Alzheimer's disease , 2009, Brain Research.

[7]  B. Spann,et al.  Transcriptome Analysis of Synaptoneurosomes Identifies Neuroplasticity Genes Overexpressed in Incipient Alzheimer's Disease , 2009, PloS one.

[8]  Chris J. McBain,et al.  The Role of the GluR2 Subunit in AMPA Receptor Function and Synaptic Plasticity , 2007, Neuron.

[9]  K. Jellinger,et al.  Neuropathological evaluation of mixed dementia , 2007, Journal of the Neurological Sciences.

[10]  R. Malinow,et al.  AMPAR Removal Underlies Aβ-Induced Synaptic Depression and Dendritic Spine Loss , 2006, Neuron.

[11]  Eric H. Chang,et al.  AMPA receptor downscaling at the onset of Alzheimer's disease pathology in double knockin mice. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[12]  S. Lipton,et al.  Suppression of Cyclin-Dependent Kinase 5 Activation by Amyloid Precursor Protein: A Novel Excitoprotective Mechanism Involving Modulation of Tau Phosphorylation , 2005, The Journal of Neuroscience.

[13]  C. Ballard,et al.  Towards defining the neuropathological substrates of vascular dementia , 2004, Journal of the Neurological Sciences.

[14]  S. Gandy,et al.  Differential preservation of AMPA receptor subunits in the hippocampi of Alzheimer's disease patients according to Braak stage , 2004, Experimental Neurology.

[15]  P. Francis.  Glutamatergic systems in Alzheimer's disease , 2003, International journal of geriatric psychiatry.

[16]  K. Jellinger,et al.  The pathology of ischemic-vascular dementia An update , 2002, Journal of the Neurological Sciences.

[17]  D. Selkoe.  Alzheimer's Disease Is a Synaptic Failure , 2002, Science.

[18]  G. Lynch,et al.  Remembrance of Arguments Past: How Well Is the Glutamate Receptor Hypothesis of LTP Holding Up after 20 Years? , 2001, Neurobiology of Learning and Memory.

[19]  B. Meldrum,et al.  Glutamate as a neurotransmitter in the brain: review of physiology and pathology. , 2000, The Journal of nutrition.

[20]  R. Dingledine,et al.  The glutamate receptor ion channels. , 1999, Pharmacological reviews.

[21]  J. Olney,et al.  Excitotoxic neurodegeneration in Alzheimer disease. New hypothesis and new therapeutic strategies. , 1997, Archives of neurology.

[22]  P. Davies,et al.  The Loss of GluR2(3) Immunoreactivity Precedes Neurofibrillary Tangle Formation in the Entorhinal Cortex and Hippocampus of Alzheimer Brains , 1997, Journal of neuropathology and experimental neurology.

[23]  P. Francis.  Pyramidal neurone modulation: a therapeutic target for Alzheimer's disease. , 1996, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.

[24]  N. Sims,et al.  Cortical Pyramidal Neurone Loss May Cause Glutamatergic Hypoactivity and Cognitive Impairment in Alzheimer's Disease: Investigative and Therapeutic Perspectives , 1993, Journal of neurochemistry.

[25]  G. C. Román,et al.  Vascular dementia , 1993, Neurology.

[26]  S. M. Sumi,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.

[27]  F. Fonnum.  Glutamate: A Neurotransmitter in Mammalian Brain , 1984, Journal of neurochemistry.

[28]  J. Coyle,et al.  Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. , 1982, Science.

[29]  S. Folstein,et al.  “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician , 1975 .

[30]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[31]  K. Jellinger.  Vascular-ischemic dementia: an update. , 2002, Journal of neural transmission. Supplementum.

[32]  G. V. Van Hoesen,et al.  The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. , 1991, Cerebral cortex.

[33]  H. Chui,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group. Definitions and Terminology Subcortical Ischaemic Vascular Dementia Subcortical Ischaemic Vascular Dementia Panel 1. Clinicopathological Classification of Vascular Dementia , 2022 .